Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC

Conditions: Triple-negative Breast Cancer Interventions: Drug: Pembrolizumab 25 mg/ml; Drug: Paclitaxel injection Sponsors: UNICANCER; MSD France; Vall d ' Hebron Institute of Oncology; SOLTI Breast Cancer Research Group Not yet recruiting

https://clinicaltrials.gov/study/NCT06078384

Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials